Limb lymphedema as a first manifestation of primary intestinal lymphangiectasia (Waldmann's disease);Lymphangiectasies intestinales primitives (maladie de Waldmann) révélées par un lymphœdème des membres

Journal des Maladies Vasculaires

Volumn 29, Issue 2, 2004, Pages 103-106

  Boursier, V ^a   Vignes, S ^a  

^a Hopital de la Fondation Cognacq Jay   (France)

Author keywords

Lymphedema; Primary intestinal lymphangiectasia; Waldmann's disease

Indexed keywords

ADULT; ARM; ARTICLE; B CELL LYMPHOMA; BANDAGE; CASE REPORT; CHRONIC DIARRHEA; CLINICAL FEATURE; DISEASE COURSE; DUODENUM BIOPSY; HUMAN; HYPOGAMMAGLOBULINEMIA; HYPOPROTEINEMIA; INTESTINE LYMPHANGIECTASIA; LEG; LYMPHEDEMA; LYMPHOCYTOPENIA; LYMPHOSCINTIGRAPHY; MALE; PERIPHERAL EDEMA; PROTEIN LOSING GASTROENTEROPATHY; STRETCHING;

EID: 3042671834     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0398-0499(04)96722-4     Document Type: Article

References (17)

1. WALDMANN TA, STEINFELD JL, DUTCHER TF, et al. The role of gastrointestinal system in "idiopathic hypoproteinemia". Gastroenterology, 1961; 41: 197-207.
2. VARDY PA, LEBENTHAL E, SHWACHMAN H. Intestinal lymphangiectasia: a reappraisal. Pediatrics, 1975; 55: 842-50.
3. LE BOUGEANT P, DELBREL X, GRENOUILLET M, et al. Maladie de Waldmann familiale. Ann Med Interne, 2000; 151: 511-2.
4. WALDMANN TA. Protein-losing enteropathy. Gastroenterology, 1966; 50: 422-43.
5. LIGNY G, VAN CAUTER J, ENGELHOM L, et al. Lymphangiectasies et entéropathie exsudative. Acta Gastroenterol Belg, 1981; 44: 469-82.
6. FOX U, LUCANI G. Disorders of the intestinal mesenteric lymphatic system. Lymphology, 1993; 26: 61-6.
7. BEN BOUALI A, ARMAND P, BARTHE JP, et al. Lymphangiectasie primitive ou maladie de Waldmann. Sem Hôp Paris, 1979; 55: 1935-40.
8. MUNK A, SOSA VALENCIA G, FAURE C, et al. Suivi de long cours des lymphangiectasies intestinales primitives de l'enfant. A propos de six cas. Arch Pédiatr, 2002; 9: 388-91.
9. DESRAMÉ J, BÉCHADE D, PATTE JH, et al. Syndrome des ongles jaunes associés à des lymphangiectasies intestinales. Gastroenterol Clin Biol, 2000; 24: 837-40.
10. FUSS IJ, STROBER W, CUCCHERINI BA, et al. Intestinal lymphangiectasia, a disease characterized by a selective loss of naïve CD45RA+ lymphocytes into the gastrointestinal tract. Eur J Immunol, 1998; 28: 4275-85.
11. WEIDEN PL, BLAESE RM, STROBER W, et al. Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man. J Clin Invest, 1972; 51: 1319-25.
12. STROBER W, WOCHNER RD, CARBONE PP. Intestinal lymphangiectasia: a protein losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection. J Clin Invest, 1967; 46: 1643-56.
13. LESTER LA, ROTHBERG RM, KRANTMAN HJ, et al. Intestinal lymphangiectasia and bilateral pleural effusions: effects of dietary therapy and surgical intervention on immunologic and pulmonary parameters. J Allergy Clin Immunol, 1986; 78: 891-7.
14. KLINGENBERG RD, HOMANN N, LUDWIG D. Type I intestinal lymphangiectasia treated successfully with slow-release octreotide. Dig Dis Sci, 2003; 48: 1506-9.
15. KUROIWA G, TAKAYAMA T, SATO Y, et al. Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol, 2001; 36: 129-32.
16. HARRIS SR, HUGI MR, OLIVOTTO IA, et al. Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ, 2001; 164: 191-9.
17. BOUHNIK Y, ETIENNEY I, NEMETH J, et al. Very late onset small intestinal B cell lymphoma associated with primary intestinal lymphangiectasia and diffuse cutaneous warts. Gut, 2000; 47: 296-300.